sharetrader
Page 3 of 351 FirstFirst 12345671353103 ... LastLast
Results 41 to 60 of 7017

Thread: BLT (Blis)

  1. #41
    Member
    Join Date
    Aug 2002
    Location
    pukekohe, , New Zealand.
    Posts
    103

    Default

    maybe DSM is in discussion to buy into BLT and therefore negate the issue of a share placement to the shareholders?

  2. #42
    Member
    Join Date
    Mar 2006
    Location
    Waimamaku, Northland NZ
    Posts
    114

    Smile

    That's an interesting thought Neopole. I just re-read the last annual report ...

    "BLIS Technologies requires new capital to further progress the new strategy. As previously stated, the Company is seeking an international partner to take up equity in BLIS. Assuming that the arrangements for such a placement are secured, the Directors will then seek shareholder approval for the transaction.

    The Directors will also seek approval from shareholders in August for a rights issue to existing shareholders..."

    I hadn't noticed the confident tone of that 3rd sentence ...and the rights issue sounds like an add-on comment rather than the main thrust. The main point is the expected corner-stone shareholder which they anticipate as being sooner than later.

    I'd better join that buyer's queue before the rush!

  3. #43
    Member
    Join Date
    Jun 2007
    Location
    , , .
    Posts
    98

    Default

    Assuming their is a rights issue, Any shareholders here
    going to take up their rights?

    I probably will, but it depends on the deal.
    It would be good if their were some options for say BLT in
    3 years time, that would make it interesting.

    If the Nestle deal and DSM work.

  4. #44
    Member Scuffer's Avatar
    Join Date
    May 2007
    Location
    , , .
    Posts
    347

    Smile

    If Nestle and DSM are really comitted they will be making sure they have got a good deal now before BLT find themselves in a position to not need them financially, the idea of going to the shareholders for more money makes me think that these companies are not exactly falling over to get in, but this could be a good thing for existing shareholders BLT maybe holding their cards close to their chest and not giving too much away too early, lets hope it is the latter.
    I don't bloody believe it

  5. #45
    Member
    Join Date
    Jun 2007
    Location
    , , .
    Posts
    98

    Default

    Hi Bobby whats your view on
    the delay with the rights issue?

  6. #46
    Member
    Join Date
    Sep 2004
    Location
    , , New Zealand.
    Posts
    175

    Default

    Not sure what to make of it. On the one hand, the new CEO would be only too well aware of BLIS' past propensity for giving and then missing self imposed deadlines. He would not have given a date he did not think he could stick to, due to impact on credibility. On the other hand, shareholders are never in a hurry to be tapped for cash, so maybe won't hold the delay against him. Could it be that at the time the issue was announced an underwriting arrangement was in place, but has now fallen over due to recent market turmoil and apparently reduced appetite for risk?

    To put things in perspective, we are only a few days into September, maybe nothing too serious to worry about at this stage. Have you emailed BLIS to ask them about the delay T1?

  7. #47
    Member
    Join Date
    Mar 2006
    Location
    Waimamaku, Northland NZ
    Posts
    114

    Default

    If BLT is in fact in disussions with a serious stakeholder (as hinted at several times by BLT) ...remembering that such talks may take 6-9 months ...then the idea of a rights issue to build new offices or lab capacity etc. may be under review. Stakeholders often want a strong say in business decisions.

  8. #48
    Member
    Join Date
    Jun 2007
    Location
    , , .
    Posts
    98

    Default

    Hi Bobby, i havent contacted blis.
    Maybe wait a couple of weeks.
    Actualy I am looking to buy some more especialy
    at todays prices.

  9. #49
    Member
    Join Date
    Mar 2006
    Location
    Waimamaku, Northland NZ
    Posts
    114

    Default

    I thought the NZX has controls in place to keep us informed ...a level playing field etc?

    BLT stated they have a rights issue to be announced in Aug ...followed by absolute silence. They ought to give an apology ...and provide the NZX share market with a reason for that delay.

    These guys seem to forget they're a NZX public listed company.

  10. #50
    Member
    Join Date
    Apr 2004
    Location
    , , .
    Posts
    241

    Default

    According to todays Otago Daily Times Blis are set to raise $3m in new capital before the end of the year, with a shareholders meeting set down for early October.
    They have also agreed to broarden their research agreement with Nestle into other probiotics.
    No doubt somebody more computer literate than I can post the article.

  11. #51
    Member
    Join Date
    Mar 2006
    Location
    Waimamaku, Northland NZ
    Posts
    114

    Default

    So the good news is here ...with the rights announcement as expected even if somewhat delayed. The end of any year isn't the best time to raise cash, but $3m isn't much so it should be okay.

  12. #52
    Member Scuffer's Avatar
    Join Date
    May 2007
    Location
    , , .
    Posts
    347

    Default

    3 mil should be no probs with all the media coverage on halitosis and the deals with the multinationals I would expect foreign money is starting to look at Blis now and ya average kiwi will be starting to get the boot out the door. The americans are starting to look into the causes for bad breath rather than trying to mask the problem.
    The only thing I find perturbing is that the multinationals are not trying to get more of a finger in the pie and the company are coming to the shareholders in the way of options.
    I don't bloody believe it

  13. #53
    Member
    Join Date
    Sep 2004
    Location
    , , New Zealand.
    Posts
    175

    Default

    The rights announcement says BLIS "intends to raise up to $3 million". Does the term "up to" imply that this issue will not be underwritten? I think it does.

  14. #54
    Member
    Join Date
    Sep 2004
    Location
    , , New Zealand.
    Posts
    175

    Default

    Here's the article from yesterday's ODT:

    Blis Technologies set to raise further $3 million

    By SIMON HARTLEY Business Reporter Friday, 21st September 2007

    DUNEDIN biotechnology company Blis Technologies intends raising another $3 million equity before the end of the year and is expanding its research agreement with giant international corporation Nestle.

    Blis is the developer and manufacturer of Blis K12, an oral probiotic for the prevention of upper respiratory infection and the treatment of chronic bad breath, but has other research under way into new products to prevent and treat bacterial infections, including tooth and gum disease, ear and throat infections and also applications for skin care, women’s health and veterinary medicine.

    A shareholder meeting will be scheduled for early October seeking approval to raise $3 million before the end of the year, to fund several items including expansion of its Dunedin facilities and boost its activities in selected international markets, chief executive Barry Richardson said in a statement yesterday. The equity raised would also be used to file additional patent applications, assist with applications for international regulatory approval and increase product development capability, Dr Richardson said.

    In late March, Blis announced Nestle would provide ‘‘significant’’ funding over three years to develop probiotics targeting upper respiratory infections in infants. Under the agreement, Nestle Nutrition, an autonomous unit within Nestle SA, would fund Blis research to develop probiotics from natural antibacterial peptides to boost immune systems in infants.

    A month later, Blis announced it had signed a distribution and marketing agreement with Auckland company Pharmabroker Sales Ltd, which represents brands in New Zealand such as Colgate Oral Care, Grans Remedy, Zrytec, Buccaline and No Jet Lag.

    Dr Richardson said yesterday Nestle and Blis had recently agreed to broaden their research into other probiotics, other than Blis K12, which had formed the basis of the initial agreement. ‘‘Nestle Nutrition will commercialise the probiotics under licence as part of its range of infant nutrition products.’’

    In late May Blis, for the second consecutive year, announced a loss of almost $1 million for its full year trading to March having posted a loss of $1.1 million in 2006, followed by a loss of $964,000 for the financial year.

    At its annual meeting in early August, it was first proposed by its directors that Blis seek another rights issue to raise a further $3 million. However, some shareholders were anxious the company continued to make a loss and that after six years it had reported losses of $9.6 million.

    At the time, chairman Peter Fennessy said the goal this financial year was to break even, a target he admitted would be difficult to achieve; to have positive cashflow and to triple revenue from $690,000 in 2006-07 to $2 million this financial year.

  15. #55
    Member
    Join Date
    Mar 2002
    Location
    dunedin, , New Zealand.
    Posts
    272

    Default

    i've had similar thoughts, columbus! i was particularly disappointed that they chose a probiotic for their first big product. kiwi young adults and middle-aged aren't really into prevention -- presume we're indestructible or something. it's really only children and elderly who receive/buy into preventive medicine.

    bobby, my 'hope springs eternal' read of the 'intention to raise up to $3 million', was that it might not be necessary if nestles gets a bit more enthusiastic...
    love my rosy-tinted specs. cheers.

  16. #56
    Member
    Join Date
    Mar 2006
    Location
    Waimamaku, Northland NZ
    Posts
    114

    Default

    SP sagging to 9cps again. That will cap the upper limit of the rights issue.

    Has anyone else wondered why BLT needs money for a pilot manufacturing plant in Dunedin? What's wrong with the present Aloron operation ...and wasn't BLT moving away from manufacturing? So why the change?

    If Nestle is going to do the manufacturing after development of the area of their interest then why the need for the pilot plant? ...something going on down South ...maybe a new and better manufacturing machine they want to develop.

    Now there's a thought. What if BLT starts to licence manufacturing knowhow rather than pills!

  17. #57
    Member
    Join Date
    Sep 2004
    Location
    , , New Zealand.
    Posts
    175

    Default

    BLIS Technologies Limited
    Notice of Special Meeting

    Notice is hereby given that a Special Meeting of shareholders of BLIS Technologies Limited ("the Company") will be held at the Centre for Innovation, St David Street, Dunedin at 11.00 am on Thursday, 8 November 2007.
    Business
    The business of the meeting will be to consider:
    a. the Board's proposal to conduct a renounceable rights issue by the Company for up to 44,801,079 new ordinary shares to holders of existing ordinary shares in the Company on a pro-rata basis at a rate of 2 additional shares for every 5 existing shares at an issue price of 7.5 cents. This transaction, as outlined, is referred to as the "Rights Issue"; and
    b. providing authorisation to the Board, to allot (before or after the Rights Issue) up to 19.99% of the ordinary shares on issue in the Company to one or more strategic cornerstone shareholders subject to the provisions of the Listing Rules. This transaction, as outlined, is referred to as the "Share Allotment".
    The capital raised pursuant to the Rights Issue, and any further capital raised under the Share Allotment, will enable the Company to consolidate and further expand its product range, improve its facilities, and further pursue the commercialisation of its products in selected international markets.
    The Board believes that faster progress in the commercialisation of the Company's products in international markets can be made by seeking partners with global marketing capabilities. In identifying a cornerstone shareholder(s), the Board will be looking for a strategic partner or partners who can provide assistance to the Company in relation to its ongoing capital, marketing, and regulatory issues and the distribution of its products
    A more detailed definition and explanation of the components of these transactions is set out in the Explanatory Notes. The Explanatory Notes also explain the rationale for the Rights Issue and Share Allotment and the implications of these transactions for the Company.
    Shareholders should also refer to the annual financial results for the Company for the period ending 31 March 2007 which are set out the 2007 Annual Report and to the presentations by the Chairman and the Chief Executive at the Company's Annual General Meeting on 1 August 2007 (refer to the Company's website for details www.blis.co.nz).
    The necessary resolutions are set out below.
    Capitalised terms which are frequently used are defined in the Definition section at the end of this Notice. Others are defined in the context in which they are used.
    Resolutions
    1 Rights Issue
    To consider, and if thought fit, to pass the following special resolution:
    "That the shareholders authorise for the purposes of section 129 of the Companies Act (and Listing Rule 9.1.1 if and to the extent necessary), the Board to proceed with the Rights Issue ("Rights Issue" being defined in the Explanatory Notes to the Notice of Special Meeting dated 15 October 2007)."
    See Explanatory Notes

    2 Share Allotment
    To consider, and if thought fit, to pass the following special resolution:
    "That the shareholders authorise for the purposes of Listing Rule 7.3.1(a) (and Listing Rule 9.1.1 and section 129 of the Companies Act, if and to the extent necessary) the Board to proceed (before or after the Rights Issue) with the Share Allotment, being the allotment of up to 19.99% of the issued share capital of the Company to a strategic partner or partners (being neither a Director or any Related Party) within 12 months of the approval of this resolution at a price per share which represents no more than a 5% discount to the Issue Price payable per New Share under the Rights Issue. ("Share Allotment" being defined in more detail in the Explanatory Notes to the Notice of Special Meeting dated 15 October 2007)."
    See Explanatory Notes

    Proxies
    All shareholders are entitled to attend and vote at the meeting or to appoint a proxy to attend and vote in their place. A proxy need not be a shareholder of the Company. Individuals who are disqualified from voting on any resolution are unable to vote on a discretionary proxy.

    Enclosed with this Notice of Special Meeting is a proxy form. For the appointment of a proxy to be valid, the form must be deposited at BLIS Technologies Limited, Level 1, Centre for Innovation, 87 St. David Street, Dunedin or sent by facsimile to (03) 479 8954 no later than 48 hours before the start of the meeting being no later than 11.00 am on Tuesday, 6 November 2007. Postal voting is not permitted.
    All of the directors offer themselves as proxy to shareholders and, subject to the restriction that they cannot vote a discretionary proxy if they themselves are disqualified from voting, will vote in favour of all of the resolutions put to the meeting unless otherwise directed.

    Corporate representatives
    A corporation which is a shareholder may appoint a person to attend the meeting on its behalf in the same manner as that in which it could appoint a proxy. The form to appoint a proxy/corporate representative must be signed on behalf of the company by a person acting under the company's express or implied authority.
    Requisite majorities and voting

    Both special resolutions require the affirmative vote of a 75% majority of those voting in person or by proxy in order for them to be passed.
    If either special resolution of shareholders is passed, any shareholder who has cast all of the votes attached to their shares (and having the same beneficial owner) against either resolution, is entitled to require the Company to purchase those shares in accordance with section 111 of the Companies Act. The Company must purchase those shares unless it obtains relief under section 114 of the Companies Act. The Company would seek such relief if as a consequence of the exercise of such rights, the Board formed the view that any of the grounds set out in section 114 existed.
    By order of the board of directors



    P. F. Fennessy
    Chairman
    15 October 2007

  18. #58
    Member
    Join Date
    Sep 2004
    Location
    , , New Zealand.
    Posts
    175

    Default

    What I want to know is: has a cornerstone shareholder been identified, or is the part "b" of this transaction simply designed to encourage participation in the rights issue? Cynical, I know, but it comes from being a BLIS shareholder of long standing, who has heard all this talk of partnerships many times before.

  19. #59
    Member
    Join Date
    Jun 2007
    Location
    , , .
    Posts
    98

    Default

    Hey bobby what do you reckon about the option to
    alot 20% of company at 7.125 cents?
    Opens the door wide open for Nestle or DSM which i think is
    a good thng.
    Surely they would jump at the chance to buy such a big parcel at such a low price?
    DSM is looking for acquistitions like blis apparently.
    Maybe thats why they have been dragging it out using the rights issue as bait. Wishfull thinking maybe.

    Barry holds around 4 million shares which is alot of motivation for him, perhaps the rights issue is another way for him to get more?
    Looks as though he is a very clever strategic thinker.
    Apparently has done well in the past at Tatua and Westland.

    Hopefully something will happen before the end of the year.
    Should hopefuly do well over the next 5 years though.
    I have bet the farm on this one!

  20. #60
    Member
    Join Date
    Mar 2006
    Location
    Waimamaku, Northland NZ
    Posts
    114

    Default

    Bobby, there's a possible answer to your question in item #2 '...share Allotment ...the Board to proceed (before or after the Rights Issue) with the Share Allotment'.

    The word "before" may be a hint of negotiations already in progress? Maybe more than one party involved too?

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •